...
首页> 外文期刊>Viruses >Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein
【24h】

Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein

机译:人腺病毒55型六邻体蛋白中和表位的鉴定和应用

获取原文
           

摘要

Human adenovirus type 55 (HAdV55) is a newly identified re-emergent acute respiratory disease (ARD) pathogen with a proposed recombination of hexon gene between HAdV11 and HAdV14 strains. The identification of the neutralizing epitopes is important for the surveillance and vaccine development against HAdV55 infection. In this study, four type-specific epitope peptides of HAdV55 hexon protein, A55R1 (residues 138 to 152), A55R2 (residues 179 to 187), A55R4 (residues 247 to 259) and A55R7 (residues 429 to 443), were predicted by multiple sequence alignment and homology modeling methods, and then confirmed with synthetic peptides by enzyme-linked immunosorbent assay (ELISA) and neutralization tests (NT). Finally, the A55R2 was incorporated into human adenoviruses 3 (HAdV3) and a chimeric adenovirus rAd3A55R2 was successfully obtained. The chimeric rAd3A55R2 could induce neutralizing antibodies against both HAdV3 and HAdV55. This current study will contribute to the development of novel adenovirus vaccine candidate and adenovirus structural analysis.
机译:55型人类腺病毒(HAdV55)是一种新近鉴定出的重发性急性呼吸道疾病(ARD)病原体,具有拟议的六邻体基因在HAdV11和HAdV14株之间的重组。中和表位的鉴定对于针对HAdV55感染的监测和疫苗开发非常重要。在这项研究中,预测了HAdV55六邻体蛋白的四种类型特异性表位肽,即A55R1(残基138至152),A55R2(残基179至187),A55R4(残基247至259)和A55R7(残基429至443)。多种序列比对和同源性建模方法,然后通过酶联免疫吸附测定(ELISA)和中和试验(NT)用合成肽进行确认。最后,将A55R2掺入人腺病毒3(HAdV3)中,并成功获得嵌合腺病毒rAd3A55R2。嵌合rAd3A55R2可以诱导针对HAdV3和HAdV55的中和抗体。这项当前的研究将有助于新型腺病毒候选疫苗和腺病毒结构分析的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号